Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2021 Apr 20;12:652738. doi: 10.3389/fphar.2021.652738

Commentary: Autologous Peripheral Blood Stem Cells (PBSC) are Safe and Effective in Knee Osteoarthritis

Konstantinos I Papadopoulos 1,*, Thana Turajane 2
PMCID: PMC8093874  PMID: 33959019

Introduction

We read with interest the review of Chen et al. “The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration In Vivo: A Review” (Chen et al., 2020). Meta-analyses are a key component of evidence-based health care that by pooling together selected randomized controlled trials (RCTs) calculate an overall estimate or of the effect of the intervention under consideration (Moher and Olkin, 1995). The present review only includes one human RCT.

Materials and Methods

We believe that our RCT in 60 early osteoarthritis patients (of which 40 were actively treated with autologous hG-CSF activated PBSC and 20 received conventional hyaluronic acid treatment) (Turajane et al., 2017) should have been included. Our RCT showed statistically significant avoidance of total knee arthroplasty, and potent, early, and sustained symptom alleviation. Furthermore, our in vitro investigation (Turajane et al., 2014) shed light on the autologous PBSC mechanism of action by confirming chondrogenic differentiation potential for autologous PBSC through potentiated Sox9 transcription resulting in sequential COL-2 and aggrecan mRNA increases that ultimately resulted in histologically confirmed increased proteoglycan and glycosaminoglycan content in newly formed hyaline cartilage.

Discussion

We thus believe that the results presented in the current metanalysis are incomplete since the omitted patient number is half of the included (55 omitted vs. 130 included) (Jancewicz et al., 2004; Saw et al., 2011; Skowroński et al., 2012; Saw et al., 2013; Skowroński and Rutka, 2013; Turajane et al., 2013; Fu et al., 2014a; Saw et al., 2015). Comprising the 2017 RCT of Turajane et al. (Turajane et al., 2017) would have included a second RCT in the review, thus considerably strengthening the conclusion that autologous PBSCs show superiority in procurement, safety, and positive therapeutic effects in clinical settings where cartilage repair and regeneration are required.

Author Contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Conflict of Interest

KP was employed by THAI StemLife Co., Ltd.

The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Chen Y. R., Yan X., Yuan F. Z., Ye J., Xu B. B., Zhou Z. X., et al. (2020). The use of peripheral blood-derived stem cells for cartilage repair and regeneration in vivo: a review. Front. Pharmacol. 11, 404. 10.3389/fphar.2020.00404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fu W. L., Ao Y. F., Ke X. Y., Zheng Z. Z., Gong X., Jiang D., et al. (2014a). Repair of large full-thickness cartilage defect by activating endogenous peripheral blood stem cells and autologous periosteum flap transplantation combined with patellofemoral realignment. Knee 21, 609–612. 10.1016/j.knee.2013.10.010 [DOI] [PubMed] [Google Scholar]
  3. Jancewicz P., Dzienis W., Pietruczuk M., Skowroński J., Bielecki M. (2004). Osteochondral defects of the talus treated by mesenchymal stem cell implantation—early results. Rocz Akad Med. Bialymst. 49 (Suppl. 1), 25–27. [PubMed] [Google Scholar]
  4. Moher D., Olkin I. (1995). Meta-analysis of randomized controlled trials. JAMA 274 (24), 1962–1964. 10.1001/jama.1995.03530240072044 [DOI] [PubMed] [Google Scholar]
  5. Saw K. Y., Anz A., Merican S., Tay Y. G., Ragavanaidu K., Jee C. S. Y., et al. (2011). Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology. Arthroscopy 27, 493–506. 10.1016/j.arthro.2010.11.054 [DOI] [PubMed] [Google Scholar]
  6. Saw K. Y., Anz A., Siew-Yoke Jee C., Merican S., Ching-Soong Ng R., Roohi S. A., et al. (2013). Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy 29, 684–694. 10.1016/j.arthro.2012.12.008 [DOI] [PubMed] [Google Scholar]
  7. Saw K. Y., Anz A., Jee C. S. Y., Ng R. C. S., Mohtarrudin N., Ragavanaidu K. (2015). High tibial osteotomy in combination with chondrogenesis after stem cell therapy: a histologic report of 8 cases. Arthroscopy 31, 1909–1920. 10.1016/j.arthro.2015.03.038 [DOI] [PubMed] [Google Scholar]
  8. Skowroński J., Rutka M. (2013). Osteochondral lesions of the knee reconstructed with mesenchymal stem cells—results. Ortop. Traumatol. Rehabil. 15, 1. 10.5604/15093492.1058409 [DOI] [PubMed] [Google Scholar]
  9. Skowroński J., Rutka M., Skowroński R. (2012). Cartilage lesions of the knee treated with blood mesenchymal stem cells—results. Ortop. Traumatol. Rehabil. 14, 1–10. 10.5604/15093492.1012404 [DOI] [PubMed] [Google Scholar]
  10. Turajane T., Chaweewannakorn U., Larbpaiboonpong V., Aojanepong J., Thitiset T., Honsawek S., et al. (2013). Combination of intra-articular autologous activated peripheral blood stem cells with growth factor addition/preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell stimulation Improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease. J. Med. Assoc. Thai 96, 580. 10.1109/JPROC.2015.2471838 [DOI] [PubMed] [Google Scholar]
  11. Turajane T., Chaveewanakorn U., Fongsarun W., Aojanepong J., Papadopoulos K. I. (2017). Avoidance of total knee arthroplasty in early osteoarthritis of the knee with intra-articular implantation of autologous activated peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial with differential effects of growth factor addition. Stem Cell Int. 2017, 8925132. 10.1155/2017/8925132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Turajane T., Thitiset T., Honsawek S., Chaveewanakorn U., Aojanepong J., Papadopoulos K. I. (2014). Assessment of chondrogenic differentiation potential of autologous activated peripheral blood stem cells on human early osteoarthritic cancellous tibial bone scaffold. Musculoskelet. Surg. 98, 35–43. 10.1007/s12306-013-0303-y [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES